Analysis of Regulatory Networks and Spatial Models Uncovers Mechanisms of Immune Evasion and Resistance in Estrogen Receptor-Positive Breast Cancer - Top-Institutions - MDSpire

Analysis of Regulatory Networks and Spatial Models Uncovers Mechanisms of Immune Evasion and Resistance in Estrogen Receptor-Positive Breast Cancer

  • By

  • Yijia Fan

  • Sarthak Sahoo

  • Mohit Kumar Jolly

  • Jason T. George

  • February 23, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Breast Cancer Research
    • Molecular Oncology
    • Computational Biology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Breast Oncology
    • Cancer Genomics
    • Systems Biology

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Breast Cancer Biology
    • Endocrine Therapy
    • Immuno-oncology

  • #4

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Cancer Systems Biology
    • Breast Cancer Therapeutics
    • Computational Modeling

  • #5

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Cancer Biology
    • Immunotherapy
    • Computational Oncology

Original Source(s)

Analysis of Regulatory Networks and Spatial Models Uncovers Mechanisms of Immune Evasion and Resistance in Estrogen Receptor-Positive Breast Cancer

  • by Yijia Fan, Sarthak Sahoo, Mohit Kumar Jolly, Jason T. George

  • February 23, 2026

Related Content

This Week’s Biopharma News: New Approvals, Appeals, and AI

Datroway and Hepcludex secure notable FDA approvals, while Outlook wins its bevacizumab appeal, BioMarin reports phase 3 VOXZOGO data, and BMS partners with Anthropic

  • June 2, 2026

  • 5 min
Case Report: A rare triad of neoplasms: navigating synchronous accessory breast cancer, papillary thyroid carcinoma, and inflammatory nasal papilloma

Development and internal validation of a risk prediction model for ipsilateral upper-limb lymphedema following breast cancer surgery